Clorox (NYSE:CLX – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $150.00 to $148.00 in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.
CLX has been the topic of a number of other research reports. BNP Paribas initiated coverage on Clorox in a report on Monday, June 24th. They set an underperform rating and a $130.00 price objective on the stock. Wells Fargo & Company lowered their price objective on Clorox from $135.00 to $130.00 and set an underweight rating on the stock in a report on Wednesday, July 10th. Citigroup lowered their price objective on Clorox from $150.00 to $145.00 and set a neutral rating on the stock in a report on Wednesday, July 10th. Argus raised Clorox to a hold rating in a report on Tuesday, June 4th. Finally, Barclays lowered their price objective on Clorox from $132.00 to $122.00 and set an underweight rating on the stock in a report on Friday, July 19th. Six equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Hold and an average target price of $141.44.
Get Our Latest Stock Analysis on Clorox
Clorox Stock Performance
Clorox Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Wednesday, August 14th will be given a dividend of $1.22 per share. The ex-dividend date is Tuesday, August 13th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.42%. This is a boost from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio (DPR) is 248.71%.
Institutional Investors Weigh In On Clorox
Large investors have recently bought and sold shares of the business. Venturi Wealth Management LLC grew its position in Clorox by 308.5% during the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after acquiring an additional 145 shares during the last quarter. Northwest Financial Advisors bought a new stake in Clorox during the 4th quarter worth approximately $29,000. GoalVest Advisory LLC bought a new stake in Clorox during the 1st quarter worth approximately $31,000. First Foundation Advisors bought a new position in Clorox in the 1st quarter valued at $31,000. Finally, Core Wealth Advisors Inc. bought a new position in Clorox in the 4th quarter valued at $29,000. 78.53% of the stock is currently owned by institutional investors.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Investing in the High PE Growth Stocks
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Most Volatile Stocks, What Investors Need to Know
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- How to Use Stock Screeners to Find Stocks
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.